In agreement with our gene expression data, metformin was found to reduced serum FGF15 levels in a model of diabetic rats20, and decreased FGF19 levels was recently reported after 3 days of treatment in T2DM patients21. This evidence concerns the gene FGF19 and type 2 diabetes mellitus.